Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks •...

41
Trial Innovation Network Tackling the Critical Roadblocks in Clinical Trials Monica R. Shah, MD Director, Trial innovation Network May 6, 2017

Transcript of Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks •...

Page 1: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkTackling the Critical Roadblocks in Clinical Trials

Monica R. Shah, MD

Director, Trial innovation Network

May 6, 2017

Page 2: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Clinical TrialsThe Road is Long and Slow

Page 3: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Clinical TrialsThe Road is Long and Slow

Page 4: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Clinical Trials – Critical Roadblocks

RecruitmentChallenges

Lack of Engagement ofSite Investigators,

Providers, Participants

Fragmented Site Based Research

High Costs

Trial Start Up

Protocol Complexity

Page 5: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Clinical Trials – Critical Roadblocks

• Fewer High Quality Trials

• Insufficient Evidence to Inform Clinical Care

• IRB Review – ~112 Days• Contract Execution –

~91 Days

• Protocols often developed without

input from key stakeholders

• Lack of harmonization• Duplication of infrastructure

• Variability in training

• ~170 study procedures~ 1 million data points

subject• 25% of procedures not

related to primary or secondary endpoints

• Since 2000 –50% decline in

enrollment

• $160M to $2B• Primary drivers –

data collection, data management, study

administration

Page 6: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Clinical Trials – Critical Roadblocks

RecruitmentChallenges

Lack of Engagement ofSite Investigators,

Providers, Participants

Fragmented Site Based Research

High Costs

Trial Start Up

Protocol Complexity

• Fewer High Quality Trials

• Insufficient Evidence to Inform Clinical Care

• IRB Review – ~112 Days• Contract Execution –

~91 Days

• Protocols often developed without

input from key stakeholders

• Lack of harmonization• Duplication of infrastructure

• Variability in training

• ~170 study procedures~ 1 million data points

subject• 25% of procedures not

related to primary or secondary endpoints

• Since 2000 –50% decline in

enrollment

• $160M to $2B• Primary drivers –

data collection, data management, study

administration

Page 7: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Clinical Trials – Critical Roadblocks

RecruitmentChallenges

Lack of Engagement ofSite Investigators,

Providers, Participants

Fragmented Site Based Research

High Costs

Trial Start Up

Protocol Complexity

• Fewer High Quality Trials

• Insufficient Evidence to Inform Clinical Care

• IRB Review – ~112 Days• Contract Execution –

~91 Days

• Protocols often developed without

input from key stakeholders

• Lack of harmonization• Duplication of infrastructure

• Variability in training

• ~170 study procedures~ 1 million data points

subject• 25% of procedures not

related to primary or secondary endpoints

• Since 2000 –50% decline in

enrollment

• $160M to $2B• Primary drivers –

data collection, data management, study

administration

Page 8: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkVision

National Platform for Clinical Trials that Focuses on Operational Innovation,

Operational Excellence, and Collaboration

Resource for NIH, Industry, and Other Partners

Accelerate Translation

Page 9: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkVision

National Platform for Clinical Trials that Focuses on Operational Innovation,

Operational Excellence, and Collaboration

Resource for NIH, Industry, and Other Partners

Accelerate Translation

Page 10: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

CTSA PROGRAM HUBS: Leading excellence and innovation locally

Future Innovations & Partnerships

Trial Innovation Network

CTSA Program Data

Harmonization

CollaborativeInnovation

Awards

Boston University, Case Western Reserve University, Children's Research Institute, Columbia University, Cornell University, Dartmouth College, Duke University, Einstein-Montefiore, Emory University, Georgetown-Howard Universities, Harvard University, Icahn School of Medicine at Mount Sinai, Indiana University, Johns Hopkins University, Mayo Clinic, Medical College of Wisconsin, Medical University of South Carolina, New York University, Northwestern University, Ohio State University, Oregon Health & Science University, Pennsylvania State University, Rockefeller University, Scripps Research Institute, Stanford University, Tufts University, University at Buffalo, State University of New York, University of Alabama at Birmingham, University of California - Davis, University of California - Irvine, University of California - Los Angeles, University of California - San Diego, University of California - San Francisco, University of Chicago, University of Cincinnati, University of Colorado - Denver, University of Florida, University of Illinois at Chicago, University of Iowa, University of Kansas, University of Kentucky, University of Massachusetts, University of Miami, University of Michigan, University of Minnesota, University of New Mexico, University of North Carolina, University of Pennsylvania, University of Pittsburgh, University of Rochester, University of Southern California, University of Texas HSC at Houston, University of Texas HSC at San Antonio, University of Texas Medical Branch at Galveston, University of Texas Southwestern, University of Utah, University of Washington, University of Wisconsin -Madison, Vanderbilt University Medical Center, Virginia Commonwealth University, Wake Forest University, Washington University in St. Louis, Yale University

Collaborating regionally and nationally

CollaborationEngagement

Workforce Development

InformaticsUnderstudied Populations

MethodsProcesses

Domain Task Forces

Consortium-wide programs

Page 11: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation Network

CTSA Program Hubs

Hub Liaison Teams

Trial Innovation Centers

(TICs)

Recruitment Innovation

Centers(RIC)

Trial Innovation Network

NIH InstitutesIndustry

Foundations

PartnersParticipants

ProvidersPublic

Page 12: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation Network

CTSA Program Hubs

Hub Liaison Teams

Trial Innovation Centers

(TICs)

Recruitment Innovation

Centers(RIC)

Trial Innovation Network

NIH InstitutesIndustry

Foundations

PartnersParticipants

ProvidersPublic

Page 13: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkOperational Excellence

Trial Planning

• Protocol Design• Study and Budget Feasibility• Statistical Analysis Plan• Risk Assessment• Engagement and

Recruitment Plans• Patient Engagement Studio• Cohort Discovery Leveraging

EHR• Recruitment Training• Access to unique populations

– Rare Diseases• Key Opinion Leader/Clinical

Expertise

Trial Execution

• 3 Academic Central IRBs• Standard Agreements Used Across

Network (FDP-CTSA)• CTSA Program Recruitment Sites with Trial

Innovation Network Hub Liaison Teams• Regulatory Support• Project Management• Consent Forms, CRFs• Site Selection, Initiation, Training• Performance Metrics• Recruitment Plans and Tools• Data Management• DSMB • Study Close Out, Statistical Analysis• Publications

Page 14: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkOperational Excellence

Trial Planning

• Protocol Design• Study and Budget Feasibility• Statistical Analysis Plan• Risk Assessment• Engagement and

Recruitment Plans• Patient Engagement Studio• Cohort Discovery Leveraging

EHR• Recruitment Training• Access to unique populations

– Rare Diseases• Key Opinion Leader/Clinical

Expertise

Trial Execution

• 3 Academic Central IRBs• Standard Agreements Used Across

Network (FDP-CTSA)• CTSA Program Recruitment Sites with Trial

Innovation Network Hub Liaison Teams• Regulatory Support• Project Management• Consent Forms, CRFs• Site Selection, Initiation, Training• Performance Metrics• Recruitment Plans and Tools• Data Management• DSMB • Study Close Out, Statistical Analysis• Publications

What Makes the Trial Innovation Network Different?

Operational Innovation

• A living laboratory to study and innovate key elements of clinical trials

• Goal isn’t just to complete a trial – but to improve the clinical trials process

Page 15: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Harmonized Site Based Research System

Harmonized Data

Standards

Harmonized Recruitment

System

HarmonizedProtocol System

HarmonizedContracting

System

Harmonized CIRB System

Trial Innovation NetworkInnovating and Harmonizing to Clear Roadblocks

Delays in IRB Review

Complex Protocols

Recruitment Challenges

Data not Fully

Utilized

Fragmented Site Based Research

Delays in Contracting

Page 16: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Harmonized Site Based Research System

Harmonized Data

Standards

Harmonized Recruitment

System

HarmonizedProtocol System

HarmonizedContracting

System

Harmonized CIRB System

Trial Innovation NetworkInnovating and Harmonizing to Clear Roadblocks

Page 17: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

www.smartirb.org

Trial Innovation NetworkInnovating and Harmonizing – IRB Review

• Individual IRB reviews take too long

• SMART IRB Authorization Agreement

• 163 institutions have signed, including all 64 CTSA Hubs

• Workflows, SOPs, Metrics

Roadblock

Innovation

Page 18: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Harmonization

Trial Innovation NetworkInnovating and Harmonizing – IRB Review

Harmonized CIRB Processes

SMART IRB Agreement

Johns Hopkins

UtahVanderbilt

• 3 Harmonized Central IRBs

• All use same reliance agreement, standard procedures, and IT platform

• Metrics – time, cost, quality

Page 19: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Harmonization

Trial Innovation NetworkInnovating and Harmonizing – IRB Review

Harmonized CIRB Processes

SMART IRB Agreement

Johns Hopkins

UtahVanderbilt

• 3 Harmonized Central IRBs

• All use same reliance agreement, standard procedures, and IT platform

• Metrics – time, cost, quality

Trial Innovation NetworkOperational Innovation

• Does a harmonized IRB system increase the quality and efficiency of IRB review?

• Does a harmonized IRB system decrease burden on research staff?

Page 20: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Harmonization

Trial Innovation NetworkInnovating and Harmonizing – IRB Review

Harmonized CIRB Processes

SMART IRB Agreement

Johns Hopkins

UtahVanderbilt

• 3 Harmonized Central IRBs

• All use same reliance agreement, standard procedures, and IT platform

• Metrics – time, cost, quality

Trial Innovation NetworkOperational Innovation

• Does a harmonized IRB system increase the quality and efficiency of IRB review?

• Does a harmonized IRB system decrease burden on research staff?

National IRB System

Page 21: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Innovation and Harmonization

Roadblock

Trial Innovation NetworkInnovating and Harmonizing – Contracts

• Contract negotiations are top reason for study delay

• FDP-CTSA Master Contract • Addresses Indemnification,

Confidentiality, Publication, Intellectual Property

• Harmonized Contracting System

• MetricsTIN will use FDP-CTSA Master Contract

Kiriakis, Clin & Transl Science, 2013; www.ara4us.org

Page 22: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Innovation and Harmonization

Roadblock

Trial Innovation NetworkInnovating and Harmonizing – Contracts

• Contract negotiations are top reason for study delay

• FDP-CTSA Master Contract • Addresses Indemnification,

Confidentiality, Publication, Intellectual Property

• Harmonized Contracting System

• MetricsTIN will use FDP-CTSA Master Contract

Kiriakis, Clin & Transl Science, 2013; www.ara4us.org

Trial Innovation NetworkOperational Innovation

• Does a master contracting system decrease start up times for a clinical trial?

Page 23: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Protocols

SuboptimalProtocols

Exclusive Focus

on Science

Limited Secondary

Use Of Data

ReactiveRecruitment

Planning

InnovationRoadblock

Page 24: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Protocols

Trial Design• Novel Study Designs

• Quality by Design• Compelling

Scientific Endpoints• Feasibility

• Limit Complexity• Optimize Data

Collection• Metrics/Milestones• Develop Realistic

Budgets

Data Driven Approaches

• EHR Based Cohort Discovery and Site

Selection• Recruitment

modeling to minimize

amendments

Recruitment Planning• Engage Stakeholders

• Tailored Messages and Recruitment Material• Pre-specified Recruitment Budgets

• Monitor Recruitment Process, Metrics

Strategically Designed Protocols

Exclusive Focus

on Science

Limited Secondary

Use Of Data

ReactiveRecruitment

Planning

Execution

ProactiveRecruitment

Planning

Analytics

Innovation

TIC and RIC Collaboration

Page 25: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing - Protocols

• Vanguard for NIH-FDA Protocol Template

• Harmonized approach to comply with national requirements for registration of trials and reporting of results

• Metrics

Harmonization

Page 26: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing - Protocols

• Vanguard for NIH-FDA Protocol Template

• Harmonized approach to comply with national requirements for registration of trials and reporting of results

• Metrics

Harmonization

Trial Innovation NetworkOperational Innovation

• Does using a standard protocol template increase the efficiency of a study and quality of data?

Page 27: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Recruitment

Adapted from a slide by R. Kost, Rockefeller Univ.

Poor recruitment is a top reason for trial delays

Recruitment often addressed after problems occur

Recruitment approaches often disorganized

Research staff often not trained to implement interventions

Roadblock

Page 28: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Recruitment

Entry CriteriaMinimize Barriers

• Stringency of Entry Criteria• Time/Risks

• Adverse Events• Pain/Invasiveness

• Procedures• Lost Wages

• Language BarriersProactive Systematic Recruitment

Research Team

Protocol Design

Data Driven Cohort

Discovery and Site Selection

Engagement/Recruitment

Plans

Outreach

Advertising & Social Media

Recruitment Workflows

Participant Experience

Innovation and Harmonization

Page 29: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Recruitment

Entry CriteriaMaximize Incentives

• Engagement/Partnership• Direct Benefits

• Access to Novel Treatment• Free Testing

• Access to Test Results• Education/Learning

• Compensation

• EHR to identify participants and sites

• Recruitment models

• Target audience, patient pathways, messaging, recruitment approaches

• Engagement studios, focus groups

• Workflows • Metrics

• Assess experience of participation

• Return of results

• Recruitment training• Training for specific

populations

Proactive Systematic Recruitment

Research Team

Protocol Design

Data Driven Cohort

Discovery and Site Selection

Engagement/Recruitment

Plans

Outreach

Advertising & Social Media

Recruitment Workflows

Participant Experience

Page 30: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Recruitment

Proactive Systematic Recruitment

Research Team

Protocol Design

Data Driven Cohort

Discovery and Site Selection

Engagement/Recruitment

Plans

Outreach

Advertising & Social Media

Recruitment Workflows

Participant Experience

Optimized Recruitment

and Retention

Accelerate Trials

Page 31: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Recruitment

Entry CriteriaMinimize Barriers

• Stringency of Entry Criteria• Time/Risks

• Adverse Events• Pain/Invasiveness

• Procedures• Lost Wages

• Language Barriers

Entry CriteriaMaximize Incentives

• Engagement/Partnership• Direct Benefits

• Access to Novel Treatment• Free Testing

• Access to Test Results• Education/Learning

• Compensation

• EHR to identify participants and sites

• Recruitment models

• Target audience, patient pathways, messaging, recruitment approaches

• Engagement studios, focus groups

• Workflows • Metrics

• Assess experience of participation

• Return of results

• Recruitment training• Training for specific

populations

Adapted from a slide by R. Kost, Rockefeller Univ.

Poor recruitment is a top reason for trial delays

Recruitment often addressed after problems occur

Recruitment approaches often disorganized

Research staff often not trained to implement interventions

Roadblock

Proactive Systematic Recruitment

Research Team

Protocol Design

Data Driven Cohort

Discovery and Site Selection

Engagement/Recruitment

Plans

Outreach

Advertising & Social Media

Recruitment Workflows

Participant Experience

Optimized Recruitment

and Retention

Accelerate Trials

Innovation and Harmonization

Page 32: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Recruitment

Recruitment Toolkit Systematic Recruitment Plan

Systematic Enrollment Workflows

Page 33: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Data Standards

• Different “languages” used to describe same data

• Difficult to combine data and generate new insights

• Limits collaboration across organizations

• Decreases efficiency and quality of data collection

Tower of Babel, Pieter Bruegel

Roadblock

Page 34: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation Network Innovating and Harmonizing – Data Standards

• CDISC/CDASH

• Harmonized data collection

• Harmonized adverse event reporting

• Harmonized risk-based monitoring

• Harmonized data reporting to Trial Innovation Network Data Safety and Monitoring Boards

Innovation and Harmonization

Data StandardsAgreed upon rules that allow information to

be shared in a uniform and consistent manner

Page 35: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation Network Innovating and Harmonizing – Data Standards

• CDISC/CDASH

• Harmonized data collection

• Harmonized adverse event reporting

• Harmonized risk-based monitoring

• Harmonized data reporting to Trial Innovation Network Data Safety and Monitoring Boards

Innovation and Harmonization

Data StandardsAgreed upon rules that allow information to

be shared in a uniform and consistent manner

Trial Innovation NetworkOperational Innovation

• Do harmonized data standards produce lower data entry error rates?

• Is data quality related to the amount of data collected?

Page 36: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Site Based Research

• Workload, time, research a “secondary job”

• Complex institutional systems

• Regulatory and bureaucratic burdens

• Lack of harmonization of processes

• Variability in training and expertise of local study teams

Roadblock

Page 37: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Site Based Research

TICsHub

Liaison Team

RIC

Trial Innovation

Network

CTSA Program Hub

Innovation and Harmonization

Page 38: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Site Based Research

TICsHub

Liaison Team

RIC

Trial Innovation

Network

Medical Director

Research Staff

IRB, Contracts, Recruitment, IT

Hub Liaison Team

Manager

CTSA Hub PI

Dedicated Clinical Trial Catalyst Team

Innovation and Harmonization

Page 39: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation NetworkInnovating and Harmonizing – Site Based Research

TICsHub

Liaison Team

RIC

Trial Innovation

Network Hub Contracts Office• Operationalize Standard

Agreements

Hub Research Teams• Assist with Operationalizing

TIN Studies

Hub Recruitment• Cohort Discovery• Training• Community

Engagement

NIHIndustry

Other Partners

Hub Investigators• Encourage Ideas• Assist with Developing TIN

Proposals• Identify Investigators for TIN

Studies

Hub IRB Office• Operationalize TIN CIRB

Dedicated Clinical Trial Catalyst Team

Page 40: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

Trial Innovation Network

Page 41: Tackling the Critical Roadblocks in Clinical Trials · Clinical Trials –Critical Roadblocks • Fewer High Quality Trials • Insufficient Evidence to Inform Clinical Care • IRB

www.trialinnovationnetwork.org